Delivery Order SPE2DB24D2106-SPE2DB25FAVYT
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $20,733.91 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Otezla 30 mg tablets (60-count packages). The delivery order, which carries no set-aside designation, is scheduled for completion by August 5, 2025, with performance to occur in Conshohocken, Pennsylvania. This award is issued under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a $25,679.07 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60-count bottles of Otezla 30 mg tablets, a pharmaceutical product used to treat certain medical conditions. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract SPE2DB24D2106 with DLA, which has a ceiling value of up to $4,999,999 and enables...
- This federal contract award is a $5,435.86 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Otezla 30 mg tablets, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $29,581.75, is for the delivery of OTEZLA 30 MG TABLET 60S to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. has a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 27, 2024. The $8,422.01 order is for the pharmaceutical product Otezla 30 mg tablet, 60 count, and is part of the larger SPE2DB indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA. The SPE2DB IDC allows the DLA to issue firm fixed-price delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $7,243.22 contract is for the delivery of 60 tablets of OTEZLA 30 mg, a prescription medication. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-six thousand six hundred forty-two dollars and seventy-three cents ($26,642.73) by the Defense Logistics Agency Troop Support Medical. This order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
- The Defense Logistics Agency awarded a $97,499.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, with an ultimate completion date of August 5, 2025. This delivery order, issued under the SPE2DB Indefinite Delivery Contract valued at $500 million through November 2026, represents a continuation of the agency's pharmaceutical supply relationship with the vendor. The award carries no set-aside...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a firm fixed-price delivery order valued at $46,257.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at twenty-six thousand six hundred forty-two dollars and seventy-three cents ($26,642.73) by the Defense Logistics Agency. This order is being issued against DMS Pharmaceutical Group's existing indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will provide Ocaliva 10 mg...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB25FAVYTDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $41,446.37 to DMS Pharmaceutical Group Inc. for the supply of Otezla 30 mg tablets (60-count). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery to Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order was awarded without a set-aside designation on August 11, 2025. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the issuance of firm fixed-price orders for pharmaceutical supplies supporting military health facilities. The award demonstrates DMS Pharmaceutical Group's continued role as a critical supplier in the federal pharmaceutical supply chain, providing both branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.4k | 8/11/25 |